Correlation Between Antibe Therapeutics and Pmv Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Antibe Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibe Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antibe Therapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Antibe Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibe Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibe Therapeutics and Pmv Pharmaceuticals.

Diversification Opportunities for Antibe Therapeutics and Pmv Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Antibe and Pmv is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antibe Therapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Antibe Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibe Therapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Antibe Therapeutics i.e., Antibe Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Antibe Therapeutics and Pmv Pharmaceuticals

Assuming the 90 days horizon Antibe Therapeutics is expected to generate 1.42 times more return on investment than Pmv Pharmaceuticals. However, Antibe Therapeutics is 1.42 times more volatile than Pmv Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest  33.00  in Antibe Therapeutics on September 6, 2024 and sell it today you would lose (11.00) from holding Antibe Therapeutics or give up 33.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.66%
ValuesDaily Returns

Antibe Therapeutics  vs.  Pmv Pharmaceuticals

 Performance 
       Timeline  
Antibe Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Antibe Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Antibe Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Pmv Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Antibe Therapeutics and Pmv Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Antibe Therapeutics and Pmv Pharmaceuticals

The main advantage of trading using opposite Antibe Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibe Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.
The idea behind Antibe Therapeutics and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets